Latest Breaking News On - American journal of blood research - Page 1 : comparemela.com

Humanigen Presents Promising New Hematologic Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia Treatment at the 2023 European Hematology Association Congress

Humanigen Presents Promising New Hematologic Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia Treatment at the 2023 European Hematology Association Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of adelaideSouth australiaNew zealandUnited kingdomUnited statesCameron durrantDaniel thomasCharlotte wrayAmerican journal of blood researchTherapeutic goods administrationLeukaemia foundationResearch instituteResearch future fundLeukemia researchAustralian healthEuropean hematology association

Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia

Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesUnited kingdomShort hillsUniversity of adelaideSouth australiaNew zealandCameron durrantCharlotte wrayDaniel thomasResearch future fundAmerican association of cancer researchDrug administrationHumanigen inc nasdaqHumanigen incHumanigen australia pty ltd

Humanigen Implements Strategic Realignment of Pipeline and Resources to Achieve Key Clinical Milestones

Short Hills, New Jersey (Newsfile Corp. - July 26, 2022) - Humanigen, Inc. (NASDAQ: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on developing lenzilumab, a first-in class

United kingdomUnited statesNew zealandCameron durrantTim morrisJersey newsfile corpLeukemia researchInternational working group criteriaLeukaemia foundationResearch instituteHumanigen incAustralian healthAmerican journal of blood researchAmerican cancer societyTherapeutic goods administrationShort hills

Care Delivery Model for Patients With Severe Hemophilia A in Tehran, Iran

Researchers in Tehran, Iran, developed a model of care delivery for patients with severe hemophilia A to improve on care and the use of resources.

United statesAmerican journal of blood researchAmerican journal